Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology

Back to Medical Reference

AV reciprocating tachycardia (AVRT) overview

Published: June 19, 2009. Updated: July 29, 2009

 

Share |

Comments: (0)

Tell-a-Friend

 

  Advertisement
AVRT belongs to a group of conditions known as paroxysmal supraventricular tachycardia. These are characterized by an abrupt onset and abrupt termination. AVRT is caused by an accessory pathway in the conduction system between atria and ventricles (e.g. Wolf-Parkinson-White syndrome).

In AVRT the accessory pathway bypasses the AV node into the ventricle (orthodromic - retrograde "narrow complex" / antidromic - antegrade "wide complex").

In orthodromic AV reciprocating tachycardia (AVRT) there is conduction down the AV node and His-Purkinje system (orthodromic), then retrograde conduction up the accessory bypass tract (a reentrant circuit or an abnormal or extra electrical pathway in the heart, a kind of "short circuit.") to re-excite the atria. The accessory AV connection bypass tract represents a congenital defect, with an incidence of 3 in 1000 in the general population.

Symptoms and signs

These includes attacks of palpitations, dizziness and syncope, dyspnea, chest pain as well as anxiety. These attacks start and terminate abruptly (i.e. paroxysmal).

ECG readings

Orthodromic tachycardias typically occur at rates of l50-250 beats per minute. A retrograde P wave may be seen at the end of the QRS complex or in the early part of the ST segment. Typically, the onset of orthodromic tachycardia is abrupt, initiated by a premature atrial or ventricular complex. Concealed accessory bypass tracts account for up to 30% of clinical cases.

Treatment

Initial therapy of acute episodes of narrow-complex tachycardias, particularly AVRT includes vagal maneuvers (e.g. carotid massage, Valsalva maneuver) and, if unsuccessful, bolus administration of short-acting agents that slow or block AV nodal conduction, such as adenosine, verapamil, or diltiazem.

Chronic drug therapy may include calcium channel antagonists, beta-adrenergic antagonists, or digoxin. Radiofrequency catheter ablation now can obviate the need for such therapy in most patients.


Previous: AV nodal reentrant tachycardia (AVNRT) Next: Brugada syndrome

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

 
     

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2017
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.